No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis
- PMID: 20116863
- PMCID: PMC2854891
- DOI: 10.1016/j.jneuroim.2010.01.005
No evidence of association of the rare nsSNP rs35667974 in IFIH1 with multiple sclerosis
Abstract
Studies suggest that different autoimmune diseases share a common genetic background, in particular, an overlap between Multiple Sclerosis (MS) and type 1 diabetes (T1D) susceptibility loci has been established. A recent study found that four rare SNPs in the IFIH1 (interferon induced with helicase C domain 1) were significantly associated with T1D. To establish if these SNPs were also involved in MS susceptibility, we chose to examine the non-synonymous SNP rs35667974/Ile923Val which displayed the strongest effect in T1D and was also shown to lead to a loss of IFIH1 function in an in vitro study. We have performed the first association study to test if this rare variant is involved in MS susceptibility in a very large sample consisting of 3037 MS patients and 10,657 healthy controls recruited from Italy and the UK. This study has 99% power to demonstrate an association at the 5% level with this rare variant. Our analysis shows that the nsSNP rs35667974/Ile923Val does not have a role in susceptibility to MS.
Copyright 2010 Elsevier B.V. All rights reserved.
References
-
- Ascherio A, Munger KL. Enviromental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol. 2007;61:288–299. - PubMed
-
- Garcia-Closas M, Lubin JH. Power and sample size calculations in case-control studies of gene-environmental interactions: Comments on different approaches. Am J Epidemiol. 1999;149:689–693. - PubMed
-
- Kurtzke JF. Rating neurologic impairment in multiple sclerosis. an expanded disability status scale (EDSS) Neurology. 1983;33:1444–1452. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
